首页> Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy> NMR-based lipoprotein analysis for patients with severe hypercholesterolemia undergoing lipoprotein apheresis or PCSK9-inhibitor therapy (NAPALI-Study).

NMR-based lipoprotein analysis for patients with severe hypercholesterolemia undergoing lipoprotein apheresis or PCSK9-inhibitor therapy (NAPALI-Study).

导出 LinkOut

翻译打印收藏纠错

第一作者： Volker Jj,Schettler

第一单位： Center for Nephrology GbR, Göttingen, Germany.;BRAVE - Benefit for Research on Arterial Hypertension, Dyslipidemia and Vascular Risk and Education e.V., Göttingen, Germany.

作者： Volker Jj,Schettler ^[1] ; Florian,Muellendorff ^[2] ; Elke,Schettler ^[3] ; Christina,Platzer ^[4] ; Sabine,Norkauer ^[5] ; Ulrich,Julius ^[6] ; Claas-Lennart,Neumann ^[1]

作者单位： Center for Nephrology GbR, Göttingen, Germany.;BRAVE - Benefit for Research on Arterial Hypertension, Dyslipidemia and Vascular Risk and Education e.V., Göttingen, Germany. ^[1] Center for Nephrology GbR, Göttingen, Germany. ^[2] BRAVE - Benefit for Research on Arterial Hypertension, Dyslipidemia and Vascular Risk and Education e.V., Göttingen, Germany. ^[3] MVZ Wagnerstibbe for Clinical Chemistry, Laboratory Medicine and Pathology, Göttingen, Germany. ^[4] numares AG, Regensburg, Germany. ^[5] Lipidology and Extracorporeal Treatment and Apheresis Center, Department of Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany. ^[6]

关键词 Lipoprotein apheresis Lipoprotein particle number Proprotein convertase subtilisin/kexin type 9 inhibitor Statin therapy